Psychedelic Stocks,Shroom News Numinus Wellness and Optimi Health Submit Psilocybin Extracts For Pre-Clinical Trial Application By Dennis Mutua May 12, 2021 Mental Health and wellness company Numinus Wellness Inc. (CVE: NUMI) and producer of finest strains of functional mushrooms from Cultivation to Consumer (CTC) Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) announced having submitted...
Psychedelic Stocks,Shroom News Tryp Inks Agreement With Clinlogix for Clinical Trial Support By Dennis Mutua May 11, 2021 Pharmaceutical company specializing in identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) announced having inked a ...
Featured,Spotlight Stock,Trends & Articles Company Using Psychedelics to Treat Brain Injuries Wesana Health Goes Public on CSE By Dennis Mutua May 11, 2021 Chicago based startup using psychedelics to tread brain injuries Wesana Health Holding Inc. (CSE: WESA) announced having got listed on the Canadian Securities Exchange (CSE) on May 10 under the ticker symbol ‘WESA’. Wesana ...
Featured,Spotlight Stock,Trends & Articles Study Establishes A Positive Correlation Between Psilocybin and Creativity By Dennis Mutua May 10, 2021 A recently carried out study has established that there exists a relationship between creativity and psilocybin. The study was done by Natasha Mason, a PhD holder from Maastricht University. Professor Mason was the lead researcher...
Psychedelic Stocks,Shroom News Jamaica’s Agriculture Minister Visits Psilocybin Company Wake Network By Dennis Mutua May 10, 2021 The Minister of Agriculture and Fisheries in Jamaica Hon. Floyd Green paid a visit to the cultivation facility of Wake Jamaica Limited, a subsidiary of leading psilocybin and medicinal mushroom production and developer of genomics...
Featured,Spotlight Stock,Trends & Articles Texas House of Representatives Approves Psychedelics Research Bill By Dennis Mutua May 07, 2021 The Texas House of Representatives passed a bill advocating for the state to start conducting studies on therapeutic potential psychedelics including psilocybin and MDMA. The house voted 134:12 in favor of the bill sponsored by Re...
Psychedelic Stocks,Shroom News Gilgamesh Concludes $27 Million Series A Financing Round By Dennis Mutua May 07, 2021 Preclinical biotechnology company focused on psychedelics therapies on mental illnesses Gilgamesh Pharmaceuticals announced having closed a $27 million Series A financing round. This latest financing round by the company was concl...
Psychedelic Stocks,Shroom News Braxia Scientific Unveils New Wing For Treatment of Mental Disorders By Dennis Mutua May 06, 2021 Psychedelics company committed to medicinal mushroom and mushroom-infused products Braxia Scientific Corp. (BRAX) has unveiled ‘Braxia Health’ unit which includes its expanding line of clinics leading psychedelics research and...